Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review)

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 539-543

  Chalkia, Aikaterini K ^a   Spandidos, Demetrios A ^a   Detorakis, Efstathios T ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cornea; HPV; Pathogenesis; Pterygium; Virus

Indexed keywords

ALPHA2B INTERFERON; DNA; RNA DIRECTED DNA POLYMERASE;

COMPLICATION; CONJUNCTIVA; CYTOMEGALOVIRUS; ELECTRON THERAPY; EPSTEIN BARR VIRUS; EYE SURGERY; HERPES SIMPLEX VIRUS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTERYGIUM; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR VIRUS; ULTRAVIOLET RADIATION; VIRAL EYE INFECTION; VIRUS DETECTION; VISION; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PTERYGIUM;

EID: 84880447433     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1438     Document Type: Review

References (51)

1. Detorakis ET and Spandidos DA: Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trends and perspectives (Review). Int J Mol Med 23: 439-447, 2009.
2. Hirst LW: The Treatment of pterygium. Surv Ophthalmol 48: 145-180, 2003.
3. Coroneo MT: Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol 77: 734-739, 1993. 4. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D and Di Girolamo N: Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 178: 817-827, 2011.
4. Detorakis ET, Zaravinos A and Spandidos DA: Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med 25: 513-516, 2010.
5. Di Girolamo N, Wakefield D and Coroneo MT: Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 41: 4142-4149, 2000.
6. Tsai YY, Chiang CC, Yeh KT, Lee H and Cheng YW: Effect of TIMP-1 and MMP in pterygium invasion. Invest Ophthalmol Vis Sci 51: 3462-3467, 2010.
7. Aspiotis M, Tsanou E, Gorezis S, Ioachim E, Skyrlas A, Stefaniotou M and Malamou-Mitsi V: Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye (Lond) 21: 1095-1101, 2007.
8. Solomon A, Li DQ, Lee SB and Tseng SC: Type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci 41: 2154-2163, 2000.
9. Solomon A, Grueterich M, Li DQ, Meller D, Lee SB and Tseng SC: Overexpression of insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci 44: 573-580, 2003.
10. Detorakis ET, Sourvinos G, Tsamparlakis J and Spandidos DA: Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 82: 1324-1328, 1998.
11. Dushku N, Hatcher SL, Albert DM and Reid TW: P53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol 117: 1593-1599, 1999.
12. Soussi T, Dehouche K and Béroud C: P53 website and analysis of P53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 15: 105-113, 2000.
13. Freed-Pastor WA and Prives C: Mutant p53: one name, many proteins. Genes Dev 26: 1268-1286, 2012.
14. Detorakis ET, Drakonaki EE and Spandidos DA: Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 6: 35-41, 2000.
15. Tsai YY, Chang CC, Chiang CC, Yeh KT, Chen PL, Chang CH, Chou MC, Lee H and Cheng YW: HPV infection and p53 inactivation in pterygium. Mol Vis 15: 1092-1097, 2009.
16. Burk RD, Chen Z and Van Doorslaer K: Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 12: 281-290, 2009.
17. Detorakis ET, Sourvinos G and Spandidos DA: Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 20: 164-167, 2001.
18. Gallagher MJ, Giannoudis A, Herrington CS and Hiscott P: Human papillomavirus in pterygium. Br J Ophthalmol 85: 782-784, 2001.
19. Piras F, Moore PS, Ugalde J, Perra MT, Scarpa A and Sirigu P: Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 87: 864-866, 2003.
20. Schellini SA, Hoyama E, Shiratori CA, Sakamoto RH and Candeias JM: Lack of papillomavirus (HPV) in pterygia of a Brazilian sample. Arq Bras Oftalmol 69: 519-521, 2006.
21. Sjö NC, von Buchwald C, Prause JU, Norrild B, Vinding T and Heegaard S: Human papillomavirus and pterygium. Is the virus a risk factor? Br J Ophthalmol 91: 1016-1018, 2007.
22. Takamura Y, Kubo E, Tsuzuki S and Akagi Y: Detection of human papillomavirus in pterygium and conjunctival papilloma by hybrid capture II and PCR assays. Eye (Lond) 22: 1442-1445, 2008.
23. Rodrigues FW, Arruda JT, Silva RE and Moura KK: Polymorphism and human papillomavirus DNA associated with pterygium. Genet Mol Res 7: 1251-1258, 2008.
24. Otlu B, Emre S, Turkcuoglu P, Doganay S and Durmaz R: Investigation of human papillomavirus and Epstein-Barr virus DNAs in pterygium tissue. Eur J Ophthalmol 19: 175-179, 2009.
25. Piecyk-Sidor M, Polz-Dacewicz M, Zagórski Z and Zarnowski T: Occurrence of human papillomavirus in pterygia. Acta Ophthalmol 87: 890-895, 2009.
26. Hsiao CH, Lee BH, Ngan KW, Chuang WY, Yeung L, Yeh LK, Tan HY, Hui-Kang D and Lin KK: Presence of human papillomavirus in pterygium in Taiwan. Cornea 29: 123-127, 2010.
27. Spandidos D, Xinarianos G, Ergazaki M, Giannoudis A and Tsamparlakis J: The presence of herpesviruses in pterygium. Int J Oncol 5: 749-752, 1994.
28. Chen YF, Hsiao CH, Ngan KW, Yeung L, Tan HY, Yang KH, Huang SC and Lin KK: Herpes simplex virus and pterygium in Taiwan. Cornea 27: 311-313, 2008.
29. Karcioglu ZA and Issa TM: Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. Br J Ophthalmol 81: 595-598, 1997.
30. McDonnell JM, McDonnell PJ and Sun YY: Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci 33: 184-189, 1992.
31. Saegusa M, Takano Y, Hashimura M, Okayasu I and Shiga J: HPV type 16 in conjunctival and junctional papilloma, dysplasia, and squamous cell carcinoma. J Clin Pathol 48: 1106-1110, 1995.
32. Sjö NC, Heegaard S, Prause JU, von Buchwald C and Lindeberg H: Human papillomavirus in conjunctival papilloma. Br J Ophthalmol 85: 785-787, 2001.
33. Sjö NC, von Buchwald C, Cassonnet P, Norrild B, Prause JU, Vinding T and Heegaard S: Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol 91: 1014-1015, 2007.
34. Kiire CA and Dhillon B: The aetiology and associations of conjunctival intraepithelial neoplasia. Br J Ophthalmol 90: 109-113, 2006.
35. Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arslan A, Othieno E, Binta-Kahwa J, van Doorn LJ, Kleter B, Quint W and Weiderpass E: Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer 102: 262-267, 2010.
36. Hirst LW, Axelsen RA and Schwab I: Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol 127: 31-32, 2009.
37. Artornsombudh P, Sanpavat A, Tinnungwattana U, Tongkhomsai V, Sansopha L and Tulvatana W: Prevalence and clinicopathologic findings of conjunctival epithelial neoplasia in pterygia. Ophthalmology 120: 1337-1340.
38. Bandyopadhyay R, Nag D, Mondal SK, Gangopadhyay S, Bagchi K and Bhaduri G: Ocular surface disorder in pterygium: role of conjunctival impression cytology. Indian J Pathol Microbiol 53: 692-695, 2010.
39. Abreu AL, Souza RP, Gimenes F and Consolaro ME: A review of methods for detect human Papillomavirus infection. Virol J 9: 262, 2012.
40. Molijn A, Kleter B, Quint W and van Doorn LJ: Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 32 (Suppl 1): S43-S51, 2005.
41. Leto Md, Santos Júnior GF, Porro AM and Tomimori J: Human papillomavirus infection: etiopathogenesis, molecular biology and clinical manifestations. An Bras Dermatol 86: 306-317, 2011 (In English, Portuguese).
42. Mackay IM: Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 10: 190-212, 2004.
43. Bustin SA, Benes V, Nolan T and Pfaffl MW: Quantitative real-time RT-PCR - a perspective. J Mol Endocrinol 34: 597-601, 2005.
44. Jensen EC: Real-time reverse transcription polymerase chain reaction to measure mRNA: use, limitations, and presentation of results. Anat Rec (Hoboken) 295: 1-3, 2012.
45. Todani A and Melki SA: Pterygium current concepts in pathogenesis and treatment. Int Ophthalmol Clin 49: 21-30, 2009.
46. Jonasch E and Haluska FG: Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 6: 34-55, 2001.
47. Vann RR and Karp CL: Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 106: 91-97, 1999.
48. Karp CL, Moore JK and Rosa RH Jr: Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 108: 1093-1098, 2001.
49. Schechter BA, Schrier A, Nagler RS, Smith EF and Velasquez GE: Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea 21: 6-11, 2002.
50. Schechter BA, Rand WJ, Velazquez GE, Williams WD and Starasoler L: Treatment of conjunctival papillomata with topical interferon Alfa-2b. Am J Ophthalmol 134: 268-270, 2002.
51. Esquenazi S: Treatment of early pterygium recurrence with topical administration of interferon alpha-2b. Can J Ophthalmol 40: 185-187, 2005.